Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Laboratorios Farmaceuticos Rovi, S.A. LABFF

Set alert

Price alert · LABFF

All alert types
67.17 USD 0.00 0.00%

At close · Oct 29

90.61 Day range 90.61
67.17 52-week range 90.61
YTD
-25.87%
1 year
-25.87%
Open
90.61
Prev close
67.17
Mkt cap
3.44B
Vol
100
Avg vol
1
EPS
4.22
P/E
15.92
More statistics
Low
90.61
High
90.61

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for LABFF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

6.95 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 28.0×
FY 2016: 88.8×FY 2017: 118×FY 2018: 124×FY 2019: 62.3×FY 2020: 36.9×FY 2021: 21.9×FY 2022: 12.8×FY 2023: 14.7×FY 2024: 32.8×FY 2025: 28.0×
FY 2016 5y median 21.9× FY 2025
P/S 5.3×
FY 2016: 8.7×FY 2017: 7.4×FY 2018: 7.3×FY 2019: 6.4×FY 2020: 5.4×FY 2021: 5.2×FY 2022: 3.1×FY 2023: 3.0×FY 2024: 5.9×FY 2025: 5.3×
FY 2016 5y median 5.2× FY 2025
P/B 5.9×
FY 2016: 12.6×FY 2017: 10.6×FY 2018: 7.7×FY 2019: 7.6×FY 2020: 6.0×FY 2021: 7.1×FY 2022: 4.9×FY 2023: 4.6×FY 2024: 7.8×FY 2025: 5.9×
FY 2016 5y median 5.9× FY 2025
P/FCF 32.8×
FY 2016: 84.1×FY 2017: -1069×FY 2018: -124×FY 2019: -49.2×FY 2020: 313×FY 2021: 30.9×FY 2022: 13.7×FY 2023: 43.1×FY 2024: 59.0×FY 2025: 32.8×
FY 2016 5y median 32.8× FY 2025
EV/EBITDA 18.3×
FY 2016: 68.2×FY 2017: 76.5×FY 2018: 77.1×FY 2019: 40.8×FY 2020: 24.0×FY 2021: 16.5×FY 2022: 9.0×FY 2023: 10.4×FY 2024: 22.1×FY 2025: 18.3×
FY 2016 5y median 16.5× FY 2025
EV/Sales 5.3×
FY 2016: 8.7×FY 2017: 7.4×FY 2018: 7.1×FY 2019: 6.4×FY 2020: 5.4×FY 2021: 5.1×FY 2022: 3.1×FY 2023: 3.1×FY 2024: 6.0×FY 2025: 5.3×
FY 2016 5y median 5.1× FY 2025
FCF Yield 3.0%
FY 2016: 1.2%FY 2017: -0.1%FY 2018: -0.8%FY 2019: -2.0%FY 2020: 0.3%FY 2021: 3.2%FY 2022: 7.3%FY 2023: 2.3%FY 2024: 1.7%FY 2025: 3.0%
FY 2016 5y median 3.0% FY 2025

Profitability

Gross Margin 60.7%
FY 2016: 56.5%FY 2017: 58.7%FY 2018: 56.4%FY 2019: 55.4%FY 2020: 56.5%FY 2021: 58.6%FY 2022: 62.7%FY 2023: 58.3%FY 2024: 61.2%FY 2025: 60.7%
FY 2016 5y median 60.7% FY 2025
Operating Margin 23.3%
FY 2016: 10.7%FY 2017: 6.9%FY 2018: 5.8%FY 2019: 11.2%FY 2020: 17.8%FY 2021: 28.0%FY 2022: 31.3%FY 2023: 26.6%FY 2024: 23.5%FY 2025: 23.3%
FY 2016 5y median 26.6% FY 2025
Net Margin 18.9%
FY 2016: 9.8%FY 2017: 6.3%FY 2018: 5.9%FY 2019: 10.3%FY 2020: 14.5%FY 2021: 23.6%FY 2022: 24.4%FY 2023: 20.5%FY 2024: 17.9%FY 2025: 18.9%
FY 2016 5y median 20.5% FY 2025
ROE 21.1%
FY 2016: 14.2%FY 2017: 9.0%FY 2018: 6.2%FY 2019: 12.2%FY 2020: 16.3%FY 2021: 32.5%FY 2022: 38.4%FY 2023: 31.6%FY 2024: 23.9%FY 2025: 21.1%
FY 2016 5y median 31.6% FY 2025
ROIC 16.5%
FY 2016: 11.8%FY 2017: 7.7%FY 2018: 5.2%FY 2019: 9.6%FY 2020: 13.7%FY 2021: 27.7%FY 2022: 33.1%FY 2023: 27.8%FY 2024: 19.8%FY 2025: 16.5%
FY 2016 5y median 27.7% FY 2025
ROA 14.7%
FY 2016: 9.1%FY 2017: 5.8%FY 2018: 4.4%FY 2019: 7.7%FY 2020: 10.6%FY 2021: 20.9%FY 2022: 22.7%FY 2023: 21.3%FY 2024: 16.5%FY 2025: 14.7%
FY 2016 5y median 20.9% FY 2025

Growth (YoY)

Revenue -2.7%
FY 2016: 7.8%FY 2017: 4.0%FY 2018: 10.0%FY 2019: 25.8%FY 2020: 10.1%FY 2021: 54.5%FY 2022: 26.1%FY 2023: 1.4%FY 2024: -7.9%FY 2025: -2.7%
FY 2016 FY 2025
Operating Income -3.6%
FY 2016: 29.6%FY 2017: -32.8%FY 2018: -8.2%FY 2019: 145.4%FY 2020: 74.3%FY 2021: 142.9%FY 2022: 41.0%FY 2023: -13.9%FY 2024: -18.5%FY 2025: -3.6%
FY 2016 FY 2025
EPS (diluted) 3.0%
FY 2016: 32.5%FY 2017: -34.0%FY 2018: 0.0%FY 2019: 102.9%FY 2020: 54.9%FY 2021: 150.9%FY 2022: 35.1%FY 2023: -14.2%FY 2024: -16.6%FY 2025: 3.0%
FY 2016 FY 2025
Free Cash Flow 57.9%
FY 2016: 189.2%FY 2017: -106.9%FY 2018: -841.1%FY 2019: -176.5%FY 2020: 114.5%FY 2021: 1410.3%FY 2022: 71.6%FY 2023: -68.8%FY 2024: 31.0%FY 2025: 57.9%
FY 2016 FY 2025

Financial Health

Current Ratio 3.1×
FY 2016: 2.2×FY 2017: 2.3×FY 2018: 2.9×FY 2019: 3.0×FY 2020: 3.0×FY 2021: 2.7×FY 2022: 2.1×FY 2023: 2.5×FY 2024: 3.1×FY 2025: 3.1×
FY 2016 5y median 2.7× FY 2025
Quick Ratio 1.6×
FY 2016: 1.3×FY 2017: 1.3×FY 2018: 1.8×FY 2019: 1.5×FY 2020: 1.1×FY 2021: 1.4×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 1.0×FY 2025: 1.6×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.2×
FY 2016: 0.2×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.3×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: -0.2×FY 2017: 0.1×FY 2018: -2.2×FY 2019: 0.3×FY 2020: 0.2×FY 2021: -0.1×FY 2022: -0.2×FY 2023: 0.2×FY 2024: 0.4×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 60.8×
FY 2016: 30.9×FY 2017: 18.8×FY 2018: 24.5×FY 2019: 46.7×FY 2020: 69.8×FY 2021: 200×FY 2022: 303×FY 2023: 232×FY 2024: 73.8×FY 2025: 60.8×
FY 2016 5y median 200× FY 2025

Dividends

Dividend Yield 1.2%
FY 2016: 0.3%FY 2017: 0.4%FY 2018: 0.3%FY 2019: 0.2%FY 2020: 0.4%FY 2021: 0.6%FY 2022: 2.0%FY 2023: 2.8%FY 2024: 1.3%FY 2025: 1.2%
FY 2016 5y median 1.3% FY 2025
Payout Ratio 34.1%
FY 2016: 26.3%FY 2017: 52.3%FY 2018: 33.3%FY 2019: 11.3%FY 2020: 15.9%FY 2021: 13.8%FY 2022: 25.5%FY 2023: 40.5%FY 2024: 41.2%FY 2025: 34.1%
FY 2016 5y median 34.1% FY 2025

Annual · latest fiscal year ends 2025-12-31